John B. Thomas
Corporate Officer/Principal at NIRI NY Chapter
Profile
John B.
Thomas is a professional with a background in investor relations and public affairs.
He is currently a member of the NIRI NY Chapter.
Previously, he held positions as Vice President of Investor Relations & Public Affairs at Abbott Laboratories from 1995 to 2013, SVP of Investor Relations & Corporate Communications at Assertio Therapeutics, Inc., and Executive VP of Strategy & Investor Relations at Horizon Therapeutics Plc from 2015 to 2017.
He also served as President of Abbott Fund.
Thomas received his undergraduate degree from the University of Mississippi in 1985 and his MBA from Lake Forest Graduate School of Management in 2001.
John B. Thomas active positions
| Companies | Position | Start |
|---|---|---|
| NIRI NY Chapter | Corporate Officer/Principal | - |
Former positions of John B. Thomas
| Companies | Position | End |
|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Investor Relations Contact | 31/12/2016 |
| ABBOTT LABORATORIES | Investor Relations Contact | 30/04/2013 |
| Abbott Fund | President | - |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Investor Relations Contact | - |
| University of Mississippi | Corporate Officer/Principal | - |
Training of John B. Thomas
| University of Mississippi | Undergraduate Degree |
| Lake Forest Graduate School of Management | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| Private companies | 4 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
| NIRI NY Chapter | |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
| Abbott Fund |
- Stock Market
- Insiders
- John B. Thomas
